Cost-Effectiveness of Tirzepatide Versus Liraglutide, Both Adjunct to Diet and Exercise, for Patients with Obesity or Overweight: A UK Perspective.

Capehorn, Matthew et al.·Advances in therapy·2025·
RPEP-102982025RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
Not classified
Evidence
Not graded
Sample
Not reported

What This Study Found

Key Numbers

How They Did This

Why This Research Matters

What This Study Doesn't Tell Us

Trust & Context

Original Title:
Cost-Effectiveness of Tirzepatide Versus Liraglutide, Both Adjunct to Diet and Exercise, for Patients with Obesity or Overweight: A UK Perspective.
Published In:
Advances in therapy, 42(10), 5055-5071 (2025)
Database ID:
RPEP-10298

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / ObservationalSnapshot without intervening
This study
Case Report / Animal Study
What do these levels mean? →

Read More on RethinkPeptides

Related articles coming soon.

Cite This Study

RPEP-10298·https://rethinkpeptides.com/research/RPEP-10298

APA

Capehorn, Matthew; Johansson, Erin; Davies, Alun; Evans, Jerome; Godbeer, Fiona; van Hest, Naomi; Cotterill, Georgina; Tolley, Keith. (2025). Cost-Effectiveness of Tirzepatide Versus Liraglutide, Both Adjunct to Diet and Exercise, for Patients with Obesity or Overweight: A UK Perspective.. Advances in therapy, 42(10), 5055-5071. https://doi.org/10.1007/s12325-025-03288-3

MLA

Capehorn, Matthew, et al. "Cost-Effectiveness of Tirzepatide Versus Liraglutide, Both Adjunct to Diet and Exercise, for Patients with Obesity or Overweight: A UK Perspective.." Advances in therapy, 2025. https://doi.org/10.1007/s12325-025-03288-3

RethinkPeptides

RethinkPeptides Research Database. "Cost-Effectiveness of Tirzepatide Versus Liraglutide, Both A..." RPEP-10298. Retrieved from https://rethinkpeptides.com/research/capehorn-2025-costeffectiveness-of-tirzepatide-versus

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.